Hematologic Neoplasms clinical trials at UCSF
1 research study open to eligible people
open to eligible people ages 18 years and up
CC-90002-ST -001 is an open-label, Phase 1, dose escalation and expansion clinical study in subjects advanced, refractory solid and hematologic cancers.
San Francisco, California and other locations